| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.831 | 0.003 | 0.831 | Bronchodilator | 0.493 0.005 CID_3035453 | ||
| 0.779 | 0.004 | 0.779 | Spasmolytic | 0.68 0.007 CID_3035453 | ||
| 0.729 | 0.002 | 0.729 | Calcium channel L-type activator | 0.663 0.003 CID_3035453 | ||
| 0.72 | 0.001 | 0.72 | Phenylalanine 4-hydroxylase inhibitor | 0.514 0.002 CID_3035453 | ||
| 0.695 | 0.009 | 0.695 | Toll-Like receptor 7 agonist | 0.308 0.105 CID_3035453 | ||
| 0.69 | 0.009 | 0.69 | Toll-Like receptor agonist | 0.339 0.088 CID_3035453 | ||
| 0.671 | 0.013 | 0.699 | Antiobesity | 0.699 0.011 CID_3035453 | CID_3035453 | |
| 0.66 | 0.005 | 0.66 | Antiadrenergic | 0.263 0.016 CID_3035453 | ||
| 0.655 | 0.005 | 0.655 | Adrenaline antagonist | 0.259 0.016 CID_3035453 | ||
| 0.626 | 0.023 | 0.626 | Cyclophilin D inhibitor | 0.6 0.027 CID_3035453 | ||
| 0.605 | 0.015 | 0.605 | Vasodilator, peripheral | |||
| 0.58 | 0.007 | 0.58 | Psychostimulant | |||
| 0.575 | 0.022 | 0.575 | Aldehyde oxidase inhibitor | |||
| 0.555 | 0.006 | 0.555 | Peroxidase inhibitor | 0.331 0.032 CID_3035453 | ||
| 0.548 | 0.01 | 0.548 | Vasodilator, coronary | 0.305 0.084 CID_3035453 | ||
| 0.55 | 0.038 | 0.55 | Transcription factor NF kappa B inhibitor | 0.407 0.062 CID_3035453 | ||
| 0.524 | 0.013 | 0.524 | Hypoxia-inducible factor 1 alpha inhibitor | 0.304 0.064 CID_3035453 | ||
| 0.505 | 0.005 | 0.505 | Calcium channel activator | 0.369 0.038 CID_3035453 | ||
| 0.496 | 0.009 | 0.496 | Interleukin agonist | 0.202 0.119 CID_3035453 | ||
| 0.477 | 0.038 | 0.477 | Histamine release inhibitor | 0.43 0.06 CID_3035453 | ||
| 0.418 | 0.003 | 0.418 | Adrenaline agonist | 0.215 0.005 CID_3035453 | ||
| 0.411 | 0.006 | 0.411 | Peptidyltransferase inhibitor | 0.326 0.017 CID_3035453 | ||
| 0.41 | 0.006 | 0.41 | Anesthetic local | 0.095 0.088 CID_3035453 | ||
| 0.474 | 0.071 | 0.474 | Caspase 9 stimulant | |||
| 0.406 | 0.005 | 0.406 | M18 aspartyl aminopeptidase inhibitor | 0.227 0.026 CID_3035453 | ||
| 0.419 | 0.02 | 0.419 | Vasodilator | 0.224 0.087 CID_3035453 | ||
| 0.407 | 0.044 | 0.407 | 5 Hydroxytryptamine release stimulant | |||
| 0.366 | 0.007 | 0.366 | Acetylcholine M1 receptor antagonist | 0.157 0.068 CID_3035453 | ||
| 0.358 | 0.002 | 0.358 | Adenylate cyclase stimulant | 0.346 0.002 CID_3035453 | ||
| 0.368 | 0.021 | 0.368 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.349 | 0.004 | 0.349 | Alpha adrenoreceptor agonist | |||
| 0.376 | 0.033 | 0.376 | Free radical scavenger | 0.297 0.053 CID_3035453 | ||
| 0.357 | 0.014 | 0.357 | Tyrosine 3 hydroxylase inhibitor | 0.189 0.156 CID_3035453 | ||
| 0.392 | 0.051 | 0.55 | Cholesterol antagonist | 0.55 0.025 CID_3035453 | CID_3035453 | |
| 0.34 | 0.002 | 0.34 | Beta 3 adrenoreceptor antagonist | 0.178 0.004 CID_3035453 | ||
| 0.371 | 0.034 | 0.371 | Cardiotonic | |||
| 0.365 | 0.043 | 0.488 | Antioxidant | 0.488 0.021 CID_3035453 | CID_3035453 | |
| 0.324 | 0.007 | 0.324 | Nitric-oxide synthase stimulant | 0.172 0.149 CID_3035453 | ||
| 0.343 | 0.027 | 0.343 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.325 | 0.012 | 0.325 | Cholinergic antagonist | 0.107 0.086 CID_3035453 | ||
| 0.315 | 0.013 | 0.315 | Acetylcholine antagonist | 0.105 0.086 CID_3035453 | ||
| 0.306 | 0.009 | 0.306 | Acetylcholine muscarinic antagonist | 0.124 0.063 CID_3035453 | ||
| 0.293 | 0.003 | 0.293 | Beta adrenoreceptor antagonist | 0.129 0.008 CID_3035453 | ||
| 0.293 | 0.004 | 0.293 | Toll-Like receptor 3 antagonist | 0.164 0.011 CID_3035453 | ||
| 0.3 | 0.014 | 0.3 | Adenylate cyclase inhibitor | 0.12 0.067 CID_3035453 | ||
| 0.335 | 0.05 | 0.335 | Sodium/bile acid cotransporter inhibitor | 0.317 0.065 CID_3035453 | ||
| 0.284 | 0.003 | 0.284 | Beta 2 adrenoreceptor antagonist | 0.117 0.006 CID_3035453 | ||
| 0.344 | 0.067 | 0.519 | Antithrombotic | 0.519 0.026 CID_3035453 | CID_3035453 | |
| 0.292 | 0.017 | 0.292 | Insulin sensitizer | 0.198 0.076 CID_3035453 | ||
| 0.271 | 0.004 | 0.271 | Acetylcholine M3 receptor antagonist | |||
| 0.305 | 0.044 | 0.305 | Amyloid beta aggregation inhibitor | |||
| 0.262 | 0.002 | 0.262 | Alpha 2a adrenoreceptor agonist | 0.027 0.006 CID_3035453 | ||
| 0.27 | 0.011 | 0.27 | Expectorant | 0.129 0.045 CID_3035453 | ||
| 0.259 | 0.003 | 0.259 | Beta 1 adrenoreceptor antagonist | 0.106 0.009 CID_3035453 | ||
| 0.362 | 0.105 | 0.362 | 5 Hydroxytryptamine release inhibitor | |||
| 0.277 | 0.025 | 0.277 | Neurotrophic factor enhancer | |||
| 0.28 | 0.03 | 0.28 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.34 | 0.091 | 0.34 | GABA C receptor rho-3 antagonist | |||
| 0.296 | 0.053 | 0.296 | Antiamyloidogenic | |||
| 0.247 | 0.004 | 0.247 | Glutamate decarboxylase inhibitor | 0.13 0.018 CID_3035453 | ||
| 0.279 | 0.039 | 0.279 | Anesthetic general | |||
| 0.245 | 0.007 | 0.245 | Mucolytic | 0.146 0.034 CID_3035453 | ||
| 0.28 | 0.045 | 0.28 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.282 | 0.058 | 0.389 | Superoxide dismutase inhibitor | 0.389 0.029 CID_3035453 | CID_3035453 | |
| 0.237 | 0.017 | 0.237 | Alpha 2b adrenoreceptor antagonist | |||
| 0.296 | 0.076 | 0.296 | Interleukin 2 agonist | |||
| 0.24 | 0.025 | 0.24 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.222 | 0.006 | 0.222 | Sphingomyelinase inhibitor | 0.089 0.073 CID_3035453 | ||
| 0.318 | 0.103 | 0.318 | Calpain 2 inhibitor | |||
| 0.217 | 0.004 | 0.217 | Alpha 2 adrenoreceptor agonist | |||
| 0.326 | 0.116 | 0.497 | Antibacterial | 0.497 0.041 CID_3035453 | CID_3035453 | |
| 0.214 | 0.006 | 0.214 | Alpha 1 adrenoreceptor agonist | |||
| 0.211 | 0.007 | 0.211 | Carbonic anhydrase stimulant | 0.085 0.024 CID_3035453 | ||
| 0.233 | 0.031 | 0.233 | Protein kinase stimulant | |||
| 0.212 | 0.01 | 0.212 | Aminoacyl-tRNA synthetase inhibitor | 0.14 0.022 CID_3035453 | ||
| 0.218 | 0.024 | 0.404 | Cell wall synthesis inhibitor | 0.404 0.006 CID_3035453 | CID_3035453 | |
| 0.192 | 0.003 | 0.192 | Beta adrenoreceptor agonist | 0.074 0.005 CID_3035453 | ||
| 0.342 | 0.16 | 0.342 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.189 | 0.006 | 0.189 | Adrenaline uptake inhibitor | |||
| 0.255 | 0.074 | 0.255 | Hypoglycemic | |||
| 0.261 | 0.086 | 0.261 | Insulysin inhibitor | |||
| 0.207 | 0.032 | 0.207 | Monophenol monooxygenase inhibitor | 0.142 0.05 CID_3035453 | ||
| 0.177 | 0.002 | 0.177 | Beta 2 adrenoreceptor agonist | 0.104 0.004 CID_3035453 | ||
| 0.206 | 0.032 | 0.206 | ATPase inhibitor | |||
| 0.176 | 0.005 | 0.176 | Acetylcholine M5 receptor antagonist | |||
| 0.212 | 0.045 | 0.212 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.193 | 0.028 | 0.193 | Alkylator | 0.162 0.04 CID_3035453 | ||
| 0.171 | 0.007 | 0.171 | Glutamate (mGluR7) agonist | |||
| 0.203 | 0.04 | 0.203 | Melanin inhibitor | |||
| 0.177 | 0.017 | 0.177 | HIV-1 integrase (Overall Integration) inhibitor | 0.1 0.055 CID_3035453 | ||
| 0.187 | 0.03 | 0.256 | Cholesterol synthesis inhibitor | 0.256 0.017 CID_3035453 | CID_3035453 | |
| 0.172 | 0.022 | 0.172 | Carbonic anhydrase III inhibitor | 0.146 0.03 CID_3035453 | ||
| 0.162 | 0.012 | 0.175 | Anabolic | 0.175 0.008 CID_3035453 | CID_3035453 | |
| 0.17 | 0.023 | 0.17 | Alpha 2 adrenoreceptor antagonist | |||
| 0.231 | 0.084 | 0.231 | Calpain inhibitor | |||
| 0.17 | 0.023 | 0.17 | Vanilloid 1 agonist | 0.146 0.043 CID_3035453 | ||
| 0.171 | 0.024 | 0.171 | Alpha 2c adrenoreceptor antagonist | |||
| 0.147 | 0.002 | 0.147 | Alpha 1d adrenoreceptor agonist | 0.056 0.013 CID_3035453 | ||
| 0.158 | 0.015 | 0.158 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.191 | 0.048 | 0.191 | Amylase inhibitor | |||
| 0.159 | 0.016 | 0.159 | Electron transport complex I inhibitor | |||
| 0.163 | 0.021 | 0.194 | Gastric antisecretory | 0.194 0.013 CID_3035453 | CID_3035453 | |
| 0.194 | 0.053 | 0.194 | Succinate dehydrogenase inhibitor | |||
| 0.165 | 0.024 | 0.165 | Protein kinase C gamma inhibitor | |||
| 0.16 | 0.02 | 0.16 | Alpha 2a adrenoreceptor antagonist | |||
| 0.171 | 0.032 | 0.171 | Antibacterial (Helicobacter pylori) | 0.136 0.06 CID_3035453 | ||
| 0.166 | 0.028 | 0.166 | GABA C receptor agonist | |||
| 0.157 | 0.021 | 0.157 | Creatine kinase inhibitor | 0.084 0.081 CID_3035453 | ||
| 0.17 | 0.035 | 0.17 | Interleukin 4 antagonist | |||
| 0.154 | 0.021 | 0.154 | Urease inhibitor | |||
| 0.234 | 0.103 | 0.338 | Immunostimulant | 0.338 0.068 CID_3035453 | CID_3035453 | |
| 0.162 | 0.032 | 0.162 | Chelator | |||
| 0.134 | 0.005 | 0.134 | GABA B receptor agonist | 0.081 0.04 CID_3035453 | ||
| 0.167 | 0.038 | 0.167 | Nav1.3 sodium channel blocker | |||
| 0.3 | 0.172 | 0.3 | Apoptosis agonist | |||
| 0.128 | 0.004 | 0.128 | Diamine oxidase inhibitor | |||
| 0.153 | 0.03 | 0.153 | Carbonic anhydrase XV inhibitor | 0.103 0.063 CID_3035453 | ||
| 0.157 | 0.038 | 0.157 | Cystathionine beta-synthase inhibitor | |||
| 0.159 | 0.041 | 0.159 | Cyclooxygenase 3 inhibitor | |||
| 0.131 | 0.014 | 0.131 | Acetylcholine M2 receptor antagonist | |||
| 0.124 | 0.008 | 0.124 | Estrogen-related receptor beta agonist | |||
| 0.125 | 0.009 | 0.125 | Maillard reaction inhibitor | |||
| 0.178 | 0.063 | 0.208 | Phospholipase C inhibitor | 0.208 0.039 CID_3035453 | CID_3035453 | |
| 0.167 | 0.054 | 0.167 | GABA C receptor rho-2 antagonist | |||
| 0.144 | 0.031 | 0.144 | Mediator release inhibitor | |||
| 0.213 | 0.105 | 0.213 | DNA damaging | |||
| 0.147 | 0.039 | 0.147 | Ferrochelatase inhibitor | |||
| 0.128 | 0.021 | 0.128 | Ornithine decarboxylase inhibitor | |||
| 0.111 | 0.004 | 0.111 | Alpha 1b adrenoreceptor agonist | 0.066 0.014 CID_3035453 | ||
| 0.139 | 0.033 | 0.139 | Transcription factor STAT6 inhibitor | |||
| 0.149 | 0.044 | 0.149 | Ca2+-transporting ATPase inhibitor | |||
| 0.125 | 0.021 | 0.125 | Phosphodiesterase 6D inhibitor | 0.102 0.049 CID_3035453 | ||
| 0.144 | 0.041 | 0.144 | Microtubule formation inhibitor | |||
| 0.181 | 0.079 | 0.226 | Hepatoprotectant | 0.226 0.052 CID_3035453 | CID_3035453 | |
| 0.127 | 0.024 | 0.127 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.169 | 0.067 | 0.169 | Arachidonic acid antagonist | |||
| 0.152 | 0.051 | 0.152 | Toll-Like receptor 2 antagonist | |||
| 0.103 | 0.003 | 0.103 | Beta 1 adrenoreceptor agonist | 0.032 0.007 CID_3035453 | ||
| 0.208 | 0.112 | 0.208 | DNA synthesis inhibitor | |||
| 0.134 | 0.04 | 0.134 | GABA C receptor antagonist | |||
| 0.149 | 0.056 | 0.149 | Pregnane X receptor agonist | |||
| 0.127 | 0.034 | 0.127 | Prolactin inhibitor | |||
| 0.254 | 0.162 | 0.254 | 15-Lipoxygenase inhibitor | |||
| 0.128 | 0.036 | 0.128 | DOPA decarboxylase inhibitor | |||
| 0.115 | 0.024 | 0.115 | Histamine H2 receptor antagonist | |||
| 0.168 | 0.083 | 0.168 | Nitric oxide antagonist | 0.141 0.104 CID_3035453 | ||
| 0.151 | 0.066 | 0.476 | Hemostatic | 0.476 0.005 CID_3035453 | CID_3035453 | |
| 0.146 | 0.062 | 0.146 | MAO inhibitor | |||
| 0.109 | 0.025 | 0.109 | Vanilloid agonist | 0.097 0.036 CID_3035453 | ||
| 0.104 | 0.022 | 0.104 | Amidase inhibitor | |||
| 0.119 | 0.041 | 0.119 | GABA C receptor rho-1 antagonist | |||
| 0.133 | 0.055 | 0.133 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.143 | 0.066 | 0.143 | Neurotrophic factor | |||
| 0.116 | 0.04 | 0.116 | Nitric-oxide synthase inhibitor | |||
| 0.146 | 0.071 | 0.148 | Lipid peroxidase inhibitor | 0.148 0.07 CID_3035453 | CID_3035453 | |
| 0.151 | 0.076 | 0.151 | Interferon gamma antagonist | |||
| 0.078 | 0.004 | 0.078 | Alpha 1a adrenoreceptor agonist | 0.033 0.009 CID_3035453 | ||
| 0.09 | 0.016 | 0.09 | NMDA 2A receptor antagonist | 0.06 0.03 CID_3035453 | ||
| 0.1 | 0.028 | 0.113 | Dopamine agonist | 0.113 0.022 CID_3035453 | CID_3035453 | |
| 0.107 | 0.037 | 0.107 | NADH dehydrogenase inhibitor | |||
| 0.101 | 0.031 | 0.101 | Histidine decarboxylase inhibitor | |||
| 0.117 | 0.047 | 0.117 | Adenylate kinase inhibitor | |||
| 0.13 | 0.061 | 0.13 | DNA polymerase I inhibitor | |||
| 0.073 | 0.003 | 0.073 | Beta 3 adrenoreceptor agonist | |||
| 0.099 | 0.031 | 0.099 | Glutamate dehydrogenase inhibitor | |||
| 0.101 | 0.033 | 0.101 | Somatostatin 1 agonist | |||
| 0.12 | 0.053 | 0.12 | MAO A inhibitor | |||
| 0.102 | 0.035 | 0.102 | Inducible nitric-oxide synthase inhibitor | 0.082 0.058 CID_3035453 | ||
| 0.114 | 0.048 | 0.114 | UDP-glucose 4-epimerase inhibitor | |||
| 0.103 | 0.038 | 0.103 | Glutamate release inhibitor | |||
| 0.163 | 0.098 | 0.163 | P-glycoprotein inhibitor | |||
| 0.078 | 0.012 | 0.095 | Alpha-mannosidase inhibitor | 0.095 0.007 CID_3035453 | CID_3035453 | |
| 0.113 | 0.05 | 0.113 | Alpha adrenoreceptor antagonist | |||
| 0.132 | 0.069 | 0.132 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.099 | 0.037 | 0.099 | Myeloperoxidase inhibitor | |||
| 0.2 | 0.141 | 0.2 | Lipoxygenase inhibitor | |||
| 0.103 | 0.045 | 0.133 | NMDA receptor antagonist | 0.133 0.03 CID_3035453 | CID_3035453 | |
| 0.102 | 0.045 | 0.215 | Triose-phosphate isomerase inhibitor | 0.215 0.009 CID_3035453 | CID_3035453 | |
| 0.138 | 0.082 | 0.138 | Heat shock protein 70 antagonist | |||
| 0.068 | 0.012 | 0.088 | Mannosidase inhibitor | 0.088 0.007 CID_3035453 | CID_3035453 | |
| 0.072 | 0.016 | 0.072 | Topoisomerase II beta inhibitor | |||
| 0.069 | 0.014 | 0.069 | Stearoyl-CoA desaturase inhibitor | |||
| 0.065 | 0.01 | 0.065 | Dopamine D5 agonist | |||
| 0.122 | 0.068 | 0.122 | DNA repair enzyme inhibitor | |||
| 0.096 | 0.042 | 0.096 | Acetylcholine nicotinic antagonist | |||
| 0.171 | 0.117 | 0.171 | Hypolipemic | |||
| 0.067 | 0.015 | 0.067 | Squalene epoxidase inhibitor | |||
| 0.063 | 0.012 | 0.063 | Dopamine beta hydroxylase inhibitor | |||
| 0.096 | 0.045 | 0.096 | ATPase (Vacuolar H+) inhibitor | |||
| 0.094 | 0.043 | 0.094 | Carbonic anhydrase VI inhibitor | 0.08 0.057 CID_3035453 | ||
| 0.223 | 0.173 | 0.223 | Immunosuppressant | |||
| 0.054 | 0.005 | 0.054 | Ceramide glucosyltransferase inhibitor | 0.049 0.007 CID_3035453 | ||
| 0.091 | 0.042 | 0.091 | D-Ala-D-Ala ligase inhibitor | |||
| 0.114 | 0.065 | 0.114 | Photosensitizer | |||
| 0.077 | 0.031 | 0.096 | NMDA receptor agonist | 0.096 0.021 CID_3035453 | CID_3035453 | |
| 0.083 | 0.037 | 0.083 | MAP kinase kinase 7 inhibitor | |||
| 0.065 | 0.02 | 0.065 | Potassium channel (Inward rectifier) blocker | |||
| 0.082 | 0.036 | 0.137 | HIV-1 integrase inhibitor | 0.137 0.01 CID_3035453 | CID_3035453 | |
| 0.088 | 0.043 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.033 CID_3035453 | CID_3035453 | |
| 0.11 | 0.065 | 0.132 | Acetylcholine release stimulant | 0.132 0.032 CID_3035453 | CID_3035453 | |
| 0.073 | 0.028 | 0.073 | Dopamine uptake inhibitor | |||
| 0.085 | 0.04 | 0.176 | NMDA 2 receptor antagonist | 0.176 0.012 CID_3035453 | CID_3035453 | |
| 0.198 | 0.154 | 0.198 | 12-Lipoxygenase inhibitor | |||
| 0.071 | 0.028 | 0.071 | Protein kinase C eta inhibitor | |||
| 0.05 | 0.009 | 0.05 | Catechol O-methyltransferase inhibitor | 0.039 0.015 CID_3035453 | ||
| 0.111 | 0.072 | 0.111 | Estrogen antagonist | |||
| 0.133 | 0.094 | 0.133 | Insulin secretagoues | |||
| 0.076 | 0.037 | 0.076 | Protein kinase C beta inhibitor | |||
| 0.072 | 0.033 | 0.125 | Neuraminidase (influenza) inhibitor | 0.125 0.011 CID_3035453 | CID_3035453 | |
| 0.042 | 0.005 | 0.042 | Estrogen-related receptor gamma antagonist | |||
| 0.059 | 0.022 | 0.178 | Dopamine D2 agonist | 0.178 0.005 CID_3035453 | CID_3035453 | |
| 0.105 | 0.069 | 0.156 | Nav1.4 sodium channel blocker | 0.156 0.031 CID_3035453 | CID_3035453 | |
| 0.059 | 0.023 | 0.059 | Vanilloid 2 antagonist | 0.055 0.03 CID_3035453 | ||
| 0.041 | 0.005 | 0.041 | Calcium-sensing receptor antagonist | |||
| 0.176 | 0.141 | 0.232 | RNA-directed DNA polymerase inhibitor | 0.232 0.062 CID_3035453 | CID_3035453 | |
| 0.076 | 0.042 | 0.08 | Phospholipase D inhibitor | 0.08 0.034 CID_3035453 | CID_3035453 | |
| 0.052 | 0.019 | 0.052 | NMDA receptor subunit 3A antagonist | |||
| 0.193 | 0.16 | 0.193 | Gastrin inhibitor | |||
| 0.049 | 0.016 | 0.049 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.064 | 0.032 | 0.064 | Alcohol oxidase inhibitor | |||
| 0.063 | 0.031 | 0.063 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.046 | 0.016 | 0.049 | Phosphoglycerate kinase inhibitor | 0.049 0.014 CID_3035453 | CID_3035453 | |
| 0.034 | 0.004 | 0.034 | Alpha 2c adrenoreceptor agonist | |||
| 0.079 | 0.05 | 0.079 | Keratolytic | |||
| 0.077 | 0.048 | 0.077 | Alpha 1b adrenoreceptor antagonist | |||
| 0.106 | 0.078 | 0.106 | TRPA1 agonist | |||
| 0.065 | 0.037 | 0.089 | Neuraminidase inhibitor | 0.089 0.02 CID_3035453 | CID_3035453 | |
| 0.05 | 0.022 | 0.05 | Histamine H2 receptor agonist | |||
| 0.077 | 0.05 | 0.077 | GABA aminotransferase inhibitor | |||
| 0.034 | 0.008 | 0.057 | 1,3-Beta-glucan synthase inhibitor | 0.057 0.002 CID_3035453 | CID_3035453 | |
| 0.086 | 0.06 | 0.086 | Insulin growth factor antagonist | |||
| 0.064 | 0.038 | 0.064 | Purinergic P2X1 antagonist | |||
| 0.144 | 0.118 | 0.144 | Neurotensin receptor agonist | |||
| 0.029 | 0.004 | 0.029 | Estrogen-related receptor gamma agonist | |||
| 0.057 | 0.032 | 0.061 | Leukotriene B4 antagonist | 0.061 0.026 CID_3035453 | CID_3035453 | |
| 0.073 | 0.049 | 0.073 | Aminopeptidase I inhibitor | |||
| 0.053 | 0.03 | 0.053 | Dopamine transporter inhibitor | |||
| 0.065 | 0.042 | 0.294 | HIV-1 integrase (3'-Processing) inhibitor | 0.294 0.005 CID_3035453 | CID_3035453 | |
| 0.078 | 0.055 | 0.078 | Interferon agonist | |||
| 0.074 | 0.052 | 0.074 | Porphobilinogen synthase inhibitor | |||
| 0.095 | 0.074 | 0.095 | Estrogen receptor beta antagonist | |||
| 0.03 | 0.009 | 0.03 | Vanilloid 2 agonist | 0.028 0.012 CID_3035453 | ||
| 0.054 | 0.033 | 0.124 | Factor IXa inhibitor | 0.124 0.005 CID_3035453 | CID_3035453 | |
| 0.162 | 0.142 | 0.162 | Tumour necrosis factor alpha release inhibitor | |||
| 0.047 | 0.027 | 0.047 | NMDA receptor subunit 3B antagonist | |||
| 0.113 | 0.093 | 0.113 | NADPH oxidase inhibitor | |||
| 0.032 | 0.014 | 0.032 | Purinergic P2Y15 antagonist | |||
| 0.142 | 0.124 | 0.142 | Interleukin antagonist | |||
| 0.067 | 0.05 | 0.067 | Phosphofructokinase-1 inhibitor | |||
| 0.082 | 0.065 | 0.082 | mTOR complex 2 inhibitor | |||
| 0.055 | 0.038 | 0.055 | Sphingosine kinase 2 inhibitor | |||
| 0.064 | 0.047 | 0.246 | Selectin antagonist | 0.246 0.008 CID_3035453 | CID_3035453 | |
| 0.104 | 0.087 | 0.104 | Interleukin 8 antagonist | |||
| 0.023 | 0.007 | 0.023 | Ileal bile acid transport inhibitor | |||
| 0.089 | 0.075 | 0.094 | Bile acid receptor antagonist | 0.094 0.064 CID_3035453 | CID_3035453 | |
| 0.06 | 0.046 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.044 CID_3035453 | CID_3035453 | |
| 0.082 | 0.069 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.088 | 0.075 | 0.125 | Aminopeptidase B inhibitor | 0.125 0.05 CID_3035453 | CID_3035453 | |
| 0.062 | 0.049 | 0.062 | Interferon inducer | |||
| 0.04 | 0.028 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.077 | 0.066 | 0.077 | Glutathione S-transferase inhibitor | |||
| 0.069 | 0.059 | 0.286 | Carbonic anhydrase XIII inhibitor | 0.286 0.006 CID_3035453 | CID_3035453 | |
| 0.059 | 0.049 | 0.059 | Heme oxygenase stimulant | |||
| 0.06 | 0.051 | 0.06 | Leukotriene antagonist | |||
| 0.098 | 0.089 | 0.098 | Nav1.5 sodium channel blocker | |||
| 0.097 | 0.089 | 0.097 | Topoisomerase II inhibitor | |||
| 0.02 | 0.011 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.066 | 0.058 | 0.066 | Secretase beta inhibitor | |||
| 0.22 | 0.213 | 0.22 | Analgesic | |||
| 0.083 | 0.076 | 0.083 | Polo-like kinase-1 inhibitor | |||
| 0.075 | 0.068 | 0.075 | Insulin like growth factor 1 antagonist | |||
| 0.121 | 0.115 | 0.121 | Phospholipase A2 inhibitor | |||
| 0.083 | 0.078 | 0.083 | 5-Lipoxygenase inhibitor | |||
| 0.052 | 0.048 | 0.052 | Alpha 1d adrenoreceptor antagonist | |||
| 0.028 | 0.024 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.022 | 0.018 | 0.045 | Dopamine D1 agonist | 0.045 0.005 CID_3035453 | CID_3035453 | |
| 0.046 | 0.043 | 0.046 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.04 | 0.037 | 0.04 | Phosphorylase inhibitor | |||
| 0.193 | 0.19 | 0.193 | Apoptosis antagonist | |||
| 0.051 | 0.048 | 0.051 | Dihydroorotate oxidase inhibitor | |||
| 0.041 | 0.038 | 0.041 | Heme oxygenase inhibitor | |||
| 0.07 | 0.068 | 0.07 | Estrogen receptor alpha antagonist | |||
| 0.137 | 0.136 | 0.137 | Non-steroidal antiinflammatory agent | |||
| 0.148 | 0.147 | 0.148 | Growth factor agonist | |||
| 0.077 | 0.076 | 0.077 | Transcription factor NF kappa B stimulant | |||
| 0.037 | 0.036 | 0.037 | Oxytocin agonist | |||
| 0.018 | 0.017 | 0.018 | Antibiotic Anthracycline-like | |||
| 0.133 | 0.134 | 0.419 | Angiogenesis stimulant | 0.419 0.019 CID_3035453 | CID_3035453 | |
| 0.053 | 0.055 | 0.063 | Sphingosine kinase inhibitor | 0.063 0.034 CID_3035453 | CID_3035453 | |
| 0.059 | 0.067 | 0.08 | Catalase inhibitor | 0.08 0.047 CID_3035453 | CID_3035453 | |
| 0.021 | 0.03 | 0.028 | Thyroid hormone agonist | 0.028 0.015 CID_3035453 | CID_3035453 | |
| 0.049 | 0.06 | 0.085 | Adenine nucleotide translocase inhibitor | 0.085 0.007 CID_3035453 | CID_3035453 | |
| 0.045 | 0.057 | 0.288 | HIV-1 integrase (Strand Transfer) inhibitor | 0.288 0.005 CID_3035453 | CID_3035453 | |
| 0.041 | 0.055 | 0.078 | Carbonic anhydrase VB inhibitor | 0.078 0.023 CID_3035453 | CID_3035453 | |
| 0.039 | 0.054 | 0.067 | Aldose reductase inhibitor | 0.067 0.029 CID_3035453 | CID_3035453 | |
| 0.049 | 0.071 | 0.215 | Carbonic anhydrase V inhibitor | 0.215 0.006 CID_3035453 | CID_3035453 | |
| 0.058 | 0.083 | 0.166 | CDC25A inhibitor | 0.166 0.01 CID_3035453 | CID_3035453 | |
| 0.051 | 0.077 | 0.151 | Carbonic anhydrase VA inhibitor | 0.151 0.01 CID_3035453 | CID_3035453 | |
| 0.126 | 0.153 | 0.175 | Antimitotic | 0.175 0.1 CID_3035453 | CID_3035453 | |
| 0.052 | 0.086 | 0.118 | Cathepsin G inhibitor | 0.118 0.028 CID_3035453 | CID_3035453 | |
| 0.027 | 0.062 | 0.146 | Estrogen agonist | 0.146 0.012 CID_3035453 | CID_3035453 | |
| 0.009 | 0.054 | 0.072 | Estrogen receptor beta agonist | 0.072 0.016 CID_3035453 | CID_3035453 | |
| 0.07 | 0.121 | 0.098 | Protein kinase C zeta inhibitor | 0.098 0.053 CID_3035453 | CID_3035453 | |
| 0.052 | 0.123 | 0.088 | Glycine receptor antagonist | 0.088 0.045 CID_3035453 | CID_3035453 | |
| 0.032 | 0.104 | 0.281 | NMDA 2B receptor antagonist | 0.281 0.004 CID_3035453 | CID_3035453 | |
| 0.094 | 0.198 | 0.354 | Dual specificity phosphatase inhibitor | 0.354 0.02 CID_3035453 | CID_3035453 | |
| 0.017 | 0.137 | 0.092 | Carbonic anhydrase inhibitor | 0.092 0.03 CID_3035453 | CID_3035453 | |
| 0.076 | 0.208 | 0.253 | Diuretic | 0.253 0.03 CID_3035453 | CID_3035453 | |
| 0.009 | 0.183 | 0.057 | Factor Xa inhibitor | 0.057 0.025 CID_3035453 | CID_3035453 | |
| 0.032 | 0.218 | 0.151 | Protein-tyrosine phosphatase 1B inhibitor | 0.151 0.045 CID_3035453 | CID_3035453 | |
| 0.05 | 0.237 | 0.154 | Thrombolytic | 0.154 0.079 CID_3035453 | CID_3035453 | |
| 0.071 | 0.278 | 0.283 | Platelet adhesion inhibitor | 0.283 0.039 CID_3035453 | CID_3035453 | |
| 0.004 | 0.213 | 0.057 | Estrone sulfatase inhibitor | 0.057 0.006 CID_3035453 | CID_3035453 | |
| 0.014 | 0.237 | 0.619 | Cholecystokinin B agonist | 0.619 0.002 CID_3035453 | CID_3035453 | |
| 0.045 | 0.28 | 0.276 | Protein-tyrosine phosphatase inhibitor | 0.276 0.024 CID_3035453 | CID_3035453 | |
| 0.01 | 0.248 | 0.048 | Leukocyte elastase inhibitor | 0.048 0.025 CID_3035453 | CID_3035453 | |
| 0.049 | 0.308 | 0.314 | Dual specificity phosphatase 3 inhibitor | 0.314 0.026 CID_3035453 | CID_3035453 | |
| 0.043 | 0.335 | 0.469 | Anticoagulant | 0.469 0.012 CID_3035453 | CID_3035453 | |
| 0.017 | 0.349 | 0.091 | Thrombin inhibitor | 0.091 0.031 CID_3035453 | CID_3035453 | |
| 0.007 | 0.346 | 0.058 | NMDA 2D receptor antagonist | 0.058 0.006 CID_3035453 | CID_3035453 | |
| 0.012 | 0.399 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.015 CID_3035453 | CID_3035453 | |
| 0.004 | 0.42 | 0.211 | Cholecystokinin antagonist | 0.211 0.004 CID_3035453 | CID_3035453 | |
| 0.003 | 0.422 | 0.182 | Cholecystokinin B antagonist | 0.182 0.004 CID_3035453 | CID_3035453 | |
| 0.052 | 0.483 | 0.368 | Angiogenesis inhibitor | 0.368 0.064 CID_3035453 | CID_3035453 | |
| 0.023 | 0.455 | 0.191 | Multidrug resistance-associated protein 1 inhibitor | 0.191 0.012 CID_3035453 | CID_3035453 | |
| 0.004 | 0.464 | 0.26 | Cholecystokinin A antagonist | 0.26 0.004 CID_3035453 | CID_3035453 | |
| 0.01 | 0.471 | 0.031 | Purinergic P2Y2 antagonist | 0.031 0.027 CID_3035453 | CID_3035453 | |
| 0.003 | 0.468 | 0.583 | Cholecystokinin agonist | 0.583 0.002 CID_3035453 | CID_3035453 | |
| 0.004 | 0.479 | 0.435 | Cholecystokinin A agonist | 0.435 0.002 CID_3035453 | CID_3035453 | |
| 0.008 | 0.501 | 0.09 | Elastase inhibitor | 0.09 0.012 CID_3035453 | CID_3035453 | |
| 0.003 | 0.709 | 0.033 | Factor XI inhibitor | 0.033 0.024 CID_3035453 | CID_3035453 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |